Which psychoactives substances are found in used syringes?

被引:5
作者
Nordmann, Sandra [1 ]
Nefau, Thomas [2 ]
Micallef, Joelle [1 ]
Duplessy, Catherine [3 ]
Catusse, Jean-Christophe [4 ]
Frauger, Elisabeth [1 ]
机构
[1] AixMarseille Univ, CHU Timone, AP HM,CEIP addictovigilance PACA Corse, CNRS,sect PiiCi,UMR 7289,Inst neurosci Timone, F-13385 Marseille 5, France
[2] Univ Paris Sud, Lab Sante publ Environm, UMR 8079, F-92290 Chatenay Malabry, France
[3] Assoc SAFE, F-75015 Paris, France
[4] Ctr accueil & accompagnement & reduct risques usa, Grp PSA SOS, F-13001 Marseille, France
来源
THERAPIE | 2023年 / 78卷 / 05期
关键词
Injection drugs users; Abuse; Pharmacoepidemiology;
D O I
10.2515/therapie/2015054
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective. - The aim of this study is to analyze the residual content of used syringes. Methods. - Used syringes were collected in March 2014 at 9 sites in Marseille (automatic injection kit dispensers, streets, drug-user risk reduction centers [Centres d'accueil et d'accompagnement a la reduction de risques pour usagers de drogues [CAARUD]). Several substances (n=28) were investigated using liquid chromatography and mass spectrometry method. Results. - On average, 2 +/- 1 substances in each syringe were found among 254 syringes analyzed. The most detected substances were cocaine, buprenorphine, methylphenidate and cathinones (in 57 %, 56 %, 39 % and 19 % of the syringes respectively). Heroin and morphine were found in 10 % of the syringes. Discussion-Conclusion. - This study helps define the main substances consumed by injection drugs users. It highlighted differencies in used substances according to neighborhood and site of collection and thus help to adjust prevention and harm reduction strategies. (C) 2015 Societe francaise de pharmacologie et de therapeutique. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S51 / S57
页数:7
相关论文
共 26 条
[11]   Talc retinopathy [J].
El-Jabali, F ;
Cohen, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) :E11-E11
[12]  
Foureur N, 2013, Premiere enquete qualitative en France
[13]   OPPIDUM surveillance program: 20 years of information on drug abuse in France [J].
Frauger, Elisabeth ;
Moracchini, Christophe ;
Le Boisselier, Reynald ;
Braunstein, David ;
Thirion, Xavier ;
Micallef, Joelle .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 (06) :672-682
[14]  
GrauD VidalN, RevMedInterne2010, V31, P188
[15]  
INPES, 2015, Droguesetconduitesaddictives: comprendresavoir aider. Edition2014
[16]  
Inserm, 2015, Reduction des risques infectieux chez les usagers de drogues
[17]   Siganl Identification in Addictovigilance: the Functioning of the French System [J].
Jouanjus, Emilie ;
Gibaja, Valerie ;
Kahn, Jean-Pierre ;
Haramburu, Francoise ;
Daveluy, Amelie .
THERAPIE, 2015, 70 (02) :123-131
[18]   A European Community Pharmacy-Based Survey to Investigate Patterns of Prescription Fraud through Identification of Falsified Prescriptions [J].
Lapeyre-Mestre, Maryse ;
Gony, Mireille ;
Carvajal, Alfonso ;
Macias, Diego ;
Conforti, Anita ;
D'Incau, Paola ;
Heerdink, Rob ;
Van der Stichele, Robert ;
Bergman, Ulf .
EUROPEAN ADDICTION RESEARCH, 2014, 20 (04) :174-182
[19]   Levamisole in cocaine: Unexpected news from an old acquaintance [J].
Larocque, Alexandre ;
Hoffman, Robert S. .
CLINICAL TOXICOLOGY, 2012, 50 (04) :231-241
[20]  
Micalef J, 2015, Therapie, V70, P191